BNP Paribas Financial Markets
NMTR

BNP Paribas Financial Markets’s 9 Meters Biopharma NMTR Stock Holding History

BNP Paribas Financial Markets’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-914
Closed -$3.93K – 4839
2022
Q3 		$3.93K Buy
+914
New +$4.53K ﹤0.01% 4275
2020
Q2 		– Sell
-6
Closed -$55 – 4411
2020
Q1 		$55 Hold
6
– – ﹤0.01% 4238
2019
Q4 		$61 Sell
6
-113
-95% -$1.88K ﹤0.01% 4350
2019
Q3 		$2.55K Hold
119
– – ﹤0.01% 4345
2019
Q2 		$2.76K Sell
119
-99
-45% -$2.97K ﹤0.01% 4292
2019
Q1 		$8.42K Buy
+218
New +$9.43K ﹤0.01% 4039
2018
Q4 		– Sell
-30
Closed -$4.13K – 4468
2018
Q3 		$4.13K Hold
30
– – ﹤0.01% 4128
2018
Q2 		$14.3K Buy
+30
New +$11K ﹤0.01% 3634

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

BNP Paribas Financial Markets's NMTR Position: Q4 2022 in Review

BNP Paribas Financial Markets sold out of 9 Meters Biopharma (NMTR) in Q4 2022, closing a stake of 914 shares — an estimated $3.93K sold.

BNP Paribas Financial Markets first reported a position in NMTR in Q2 2018 and held it in 8 quarters. The position peaked at $14.3K in Q2 2018. 42 funds tracked by Wall St. Rank hold NMTR as of Q4 2022.

  • BNP Paribas Financial Markets reported no remaining 9 Meters Biopharma position as of Q4 2022 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 914 9 Meters Biopharma shares in Q4 2022, an estimated $3.93K.
  • BNP Paribas Financial Markets first reported a position in 9 Meters Biopharma in Q2 2018 and held it in 8 quarters.
  • BNP Paribas Financial Markets's 9 Meters Biopharma position peaked at $14.3K in Q2 2018.
  • 42 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2022.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2022, filed 14 Feb 2023.